Cargando…
A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibito...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010742/ https://www.ncbi.nlm.nih.gov/pubmed/35432333 http://dx.doi.org/10.3389/fimmu.2022.852119 |
_version_ | 1784687548371566592 |
---|---|
author | Nielsen, Erik Waage Miller, Yoav Brekke, Ole-Lars Grond, Joost Duong, Anh Hoang Fure, Hilde Ludviksen, Judith Krey Pettersen, Kristin Reubsaet, Leon Solberg, Rigmor Johansen, Harald Thidemann Mollnes, Tom Eirik |
author_facet | Nielsen, Erik Waage Miller, Yoav Brekke, Ole-Lars Grond, Joost Duong, Anh Hoang Fure, Hilde Ludviksen, Judith Krey Pettersen, Kristin Reubsaet, Leon Solberg, Rigmor Johansen, Harald Thidemann Mollnes, Tom Eirik |
author_sort | Nielsen, Erik Waage |
collection | PubMed |
description | Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibitor. We established a new porcine model of IRI by cross-clamping the thoracic aorta and evaluated the global changes occurring in organ function, systemic inflammatory response and organ damage with or without treatment with C1-INH-concentrate. Twenty-four piglets (8.8-11.1 kg) underwent 45 minutes clamping of the thoracic aorta at the Th8 level. Upfront 12 piglets received human saline and 12 received C1-INH (250 IU/kg) intravenously. Three sham animals received thoracic opening without clamping. Reperfusion lasted 5 hours. We studied ten cardiorespiratory markers, three hematologic markers, eleven inflammatory markers, and twelve organ damage markers over the whole experimental period. Postmortem tissue homogenates from seven organs were examined for inflammatory markers and analysed by two-way repeated-measures ANOVA, area under the curve or unpaired t-tests. By excluding sham and combining treated and untreated animals, the markers reflected a uniform, broad and severe organ dysfunction. The mean and range fold change from before cross-clamp onset to maximum change for the different groups of markers were: cardiorespiratory 1.4 (0.2-3.7), hematologic 1.9 (1.2-2.7), plasma inflammatory 19.5 (1.4-176) and plasma organ damage 2.9 (1.1-8.6). Treatment with C1-INH had only a marginal effect on the IRI-induced changes, reaching statistical significance only for the plasma complement activation product TCC (p=0.0083) and IL-4 (p=0.022) and INF-α (p=0.016) in the colon tissue. In conclusion, the present novel model of porcine global IRI is forceful with regards to central markers and could generally be applicable for pathophysiological studies. C1-INH treatment had no significant effect, but the model allows for future testing of other drugs attenuating IRI globally. |
format | Online Article Text |
id | pubmed-9010742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90107422022-04-16 A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment Nielsen, Erik Waage Miller, Yoav Brekke, Ole-Lars Grond, Joost Duong, Anh Hoang Fure, Hilde Ludviksen, Judith Krey Pettersen, Kristin Reubsaet, Leon Solberg, Rigmor Johansen, Harald Thidemann Mollnes, Tom Eirik Front Immunol Immunology Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibitor. We established a new porcine model of IRI by cross-clamping the thoracic aorta and evaluated the global changes occurring in organ function, systemic inflammatory response and organ damage with or without treatment with C1-INH-concentrate. Twenty-four piglets (8.8-11.1 kg) underwent 45 minutes clamping of the thoracic aorta at the Th8 level. Upfront 12 piglets received human saline and 12 received C1-INH (250 IU/kg) intravenously. Three sham animals received thoracic opening without clamping. Reperfusion lasted 5 hours. We studied ten cardiorespiratory markers, three hematologic markers, eleven inflammatory markers, and twelve organ damage markers over the whole experimental period. Postmortem tissue homogenates from seven organs were examined for inflammatory markers and analysed by two-way repeated-measures ANOVA, area under the curve or unpaired t-tests. By excluding sham and combining treated and untreated animals, the markers reflected a uniform, broad and severe organ dysfunction. The mean and range fold change from before cross-clamp onset to maximum change for the different groups of markers were: cardiorespiratory 1.4 (0.2-3.7), hematologic 1.9 (1.2-2.7), plasma inflammatory 19.5 (1.4-176) and plasma organ damage 2.9 (1.1-8.6). Treatment with C1-INH had only a marginal effect on the IRI-induced changes, reaching statistical significance only for the plasma complement activation product TCC (p=0.0083) and IL-4 (p=0.022) and INF-α (p=0.016) in the colon tissue. In conclusion, the present novel model of porcine global IRI is forceful with regards to central markers and could generally be applicable for pathophysiological studies. C1-INH treatment had no significant effect, but the model allows for future testing of other drugs attenuating IRI globally. Frontiers Media S.A. 2022-04-01 /pmc/articles/PMC9010742/ /pubmed/35432333 http://dx.doi.org/10.3389/fimmu.2022.852119 Text en Copyright © 2022 Nielsen, Miller, Brekke, Grond, Duong, Fure, Ludviksen, Pettersen, Reubsaet, Solberg, Johansen and Mollnes https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Nielsen, Erik Waage Miller, Yoav Brekke, Ole-Lars Grond, Joost Duong, Anh Hoang Fure, Hilde Ludviksen, Judith Krey Pettersen, Kristin Reubsaet, Leon Solberg, Rigmor Johansen, Harald Thidemann Mollnes, Tom Eirik A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title | A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title_full | A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title_fullStr | A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title_full_unstemmed | A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title_short | A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment |
title_sort | novel porcine model of ischemia-reperfusion injury after cross-clamping the thoracic aorta revealed substantial cardiopulmonary, thromboinflammatory and biochemical changes without effect of c1-inhibitor treatment |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010742/ https://www.ncbi.nlm.nih.gov/pubmed/35432333 http://dx.doi.org/10.3389/fimmu.2022.852119 |
work_keys_str_mv | AT nielsenerikwaage anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT milleryoav anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT brekkeolelars anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT grondjoost anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT duonganhhoang anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT furehilde anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT ludviksenjudithkrey anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT pettersenkristin anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT reubsaetleon anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT solbergrigmor anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT johansenharaldthidemann anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT mollnestomeirik anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT nielsenerikwaage novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT milleryoav novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT brekkeolelars novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT grondjoost novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT duonganhhoang novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT furehilde novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT ludviksenjudithkrey novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT pettersenkristin novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT reubsaetleon novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT solbergrigmor novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT johansenharaldthidemann novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment AT mollnestomeirik novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment |